Skip to main content

Bankrupt drugmaker Mallinckrodt considers sale of opioid business

By The Wall Street Journal  
   September 19, 2023

Some investors, poised to take control through chapter 11, are suggesting the company break up its business units.

Full story


Get the latest on healthcare leadership in your inbox.